Trustmark Corporation TRMK
46.04
(0.05)
(0.11%)
as of 25 Sep
- Market cap
- $2.7B
- P/E
- 11.7×
Follow TRMK
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
10.82 | 10.50 | 11.15 | 11.65 |
P/S ratio |
2.15 | 2.11 | 2.22 | 2.41 | |
P/FCF ratio |
8.84 | 10.31 | 15.09 | 14.94 | |
P/Operating CF |
36.05 | 40.76 | 91.48 | 47.38 | |
P/B ratio |
1.13 | 1.11 | 1.16 | 1.26 | |
Price to Tangible BV |
1.45 | 1.42 | 1.50 | 1.61 | |
EV/Sales |
1.65 | 1.72 | 1.96 | 2.02 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
6.45 | 7.85 | 11.59 | 10.85 | |
EV/FCF |
6.81 | 8.40 | 13.31 | 12.52 | |
Quick Ratio |
0.05 | 0.04 | 0.03 | 0.04 | |
Current Ratio |
0.88 | 0.89 | 0.89 | 0.89 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
0.99% | 1.24% | 1.23% | 1.22% | |
Debt/Equity |
0.09 | 0.11 | 0.11 | 0.11 | |
Asset Turnover |
0.06 | 0.06 | 0.06 | 0.06 | |
Operating CF/Net income |
1.17 | 1.00 | 0.48 | 0.89 | |
Capex/Depreciation |
(1.42) | (0.90) | (3.17) | (2.28) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
46.92% | 47.54% | 49.16% | 46.58% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
0.46% | 0.45% | 1.06% | 0.59% | |
Graham Net Nets |
(0.98) | (1.00) | (0.94) | (0.86) | |
Graham Number |
53.73 | 54.19 | 55.48 | 57.08 | |
Earnings Yield |
9.24% | 9.53% | 8.97% | 8.59% | |
Free Cash Flow Yield |
11.32% | 9.70% | 6.63% | 6.69% | |
Revenue per Share |
4.69 | 4.65 | 4.66 | 4.79 | |
Operating CF per Share |
1.10 | 0.96 | 0.46 | 0.97 | |
Capex per Share |
(0.08) | (0.08) | (0.16) | (0.15) | |
Free Cash Flow per Share |
1.02 | 0.88 | 0.30 | 0.82 | |
Cash per Share |
12.15 | 11.08 | 8.95 | 11.46 | |
Shareholders Equity per Share |
35.06 | 35.18 | 36.19 | 36.66 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
35.06 | 35.18 | 36.19 | 36.66 | |
Free Cash Flow |
61.28 | 52.78 | 17.82 | 48.13 | |
Working Capital |
(1,915.46) | (1,845.59) | (1,854.79) | (1,833.82) | |
Capital Expenditures |
(4.96) | (4.85) | (9.28) | (8.65) | |
Net Current Asset Value |
(2,343.36) | (2,339.57) | (2,322.93) | (2,313.59) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.03 | |
Net Profit Margin |
20.09% | 20.63% | 20.45% | 22.69% | |
Price to Operating Income |
8.88 | 8.55 | 8.94 | 9.40 | |
| Other line items | |||||
Average Payables |
15,435.95 | 15,303.98 | 15,396.61 | 15,593.54 | |
Average Assets |
18,640.94 | 18,538.82 | 18,641.76 | 18,904.07 | |
Average Common Equity |
2,047.18 | 2,042.00 | 2,075.19 | 2,107.21 |
Columns are period end dates